Movement Alert｜Johnson & Johnson Rises 3.03% in Regular Trading, Talcum Powder Lawsuit Damages Halved by Court Ruling

Market Focus06-24

On June 24, Johnson & Johnson rose 3.03% in regular trading, trading at $238.025/share, with turnover of $1.278 billion. The rally was driven by a court ruling that significantly reduced the company's talcum powder litigation liability.

A court issued a new ruling on Johnson & Johnson's talcum powder lawsuit, cutting the previously awarded damages in half to $2.1 billion. The company stated it will continue to appeal. The substantial reduction in compensation eased market concerns over the company's litigation risk exposure, providing positive short-term support for the stock price.

Within the Pharmacy sector where Johnson & Johnson belongs, the overall sector displayed warm sentiment. Among individual stocks, Ligand Pharmaceuticals up 6.1%, Merck up 3.13%, Novo-Nordisk up 2.04%, Eli Lilly up 0.64%, Pfizer down 0.74%. The broader sector strength provided additional tailwinds for Johnson & Johnson's gains.

Johnson & Johnson is a global leader in healthcare, operating through its Innovative Medicine and MedTech segments, covering therapeutic areas including immunology, oncology, neuroscience, cardiovascular, and surgical technologies.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1114805143?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-24 02:55","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1114805143","market":"us","top_or_hot":-1,"title":"Movement Alert｜Johnson & Johnson Rises 3.03% in Regular Trading, Talcum Powder Lawsuit Damages Halved by Court Ruling","media":"Market Focus","content":"<p><p>On June 24, Johnson & Johnson rose 3.03% in regular trading, trading at $238.025/share, with turnover of $1.278 billion. The rally was driven by a court ruling that significantly reduced the company's talcum powder litigation liability.</p><p>A court issued a new ruling on Johnson & Johnson's talcum powder lawsuit, cutting the previously awarded damages in half to $2.1 billion. The company stated it will continue to appeal. The substantial reduction in compensation eased market concerns over the company's litigation risk exposure, providing positive short-term support for the stock price.</p><p>Within the Pharmacy sector where Johnson & Johnson belongs, the overall sector displayed warm sentiment. Among individual stocks, Ligand Pharmaceuticals up 6.1%, Merck up 3.13%, Novo-Nordisk up 2.04%, Eli Lilly up 0.64%, Pfizer down 0.74%. The broader sector strength provided additional tailwinds for Johnson & Johnson's gains.</p><p>Johnson & Johnson is a global leader in healthcare, operating through its Innovative Medicine and MedTech segments, covering therapeutic areas including immunology, oncology, neuroscience, cardiovascular, and surgical technologies.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜Johnson & Johnson Rises 3.03% in Regular Trading, Talcum Powder Lawsuit Damages Halved by Court Ruling</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜Johnson & Johnson Rises 3.03% in Regular Trading, Talcum Powder Lawsuit Damages Halved by Court Ruling\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-06-24 02:55</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On June 24, Johnson & Johnson rose 3.03% in regular trading, trading at $238.025/share, with turnover of $1.278 billion. The rally was driven by a court ruling that significantly reduced the company's talcum powder litigation liability.</p><p>A court issued a new ruling on Johnson & Johnson's talcum powder lawsuit, cutting the previously awarded damages in half to $2.1 billion. The company stated it will continue to appeal. The substantial reduction in compensation eased market concerns over the company's litigation risk exposure, providing positive short-term support for the stock price.</p><p>Within the Pharmacy sector where Johnson & Johnson belongs, the overall sector displayed warm sentiment. Among individual stocks, Ligand Pharmaceuticals up 6.1%, Merck up 3.13%, Novo-Nordisk up 2.04%, Eli Lilly up 0.64%, Pfizer down 0.74%. The broader sector strength provided additional tailwinds for Johnson & Johnson's gains.</p><p>Johnson & Johnson is a global leader in healthcare, operating through its Innovative Medicine and MedTech segments, covering therapeutic areas including immunology, oncology, neuroscience, cardiovascular, and surgical technologies.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"JNJ","symbol_name":"强生","start_time":0,"source_url":"","article_id":"1114805143","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1114805143","pubTimestamp":1782240946,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On June 24, Johnson & Johnson rose 3.03% in regular trading, trading at $238.025/share, with turnover of $1.278 billion. The rally was driven by a court ruling that significantly reduced the...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"JNJ":"强生"},"translate_title":"动感快讯|强生常规交易涨3.03%滑石粉诉讼损失因法院裁决减半","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"JNJ":1},"content_text":"On June 24, Johnson & Johnson rose 3.03% in regular trading, trading at $238.025/share, with turnover of $1.278 billion. The rally was driven by a court ruling that significantly reduced the company's talcum powder litigation liability.A court issued a new ruling on Johnson & Johnson's talcum powder lawsuit, cutting the previously awarded damages in half to $2.1 billion. The company stated it will continue to appeal. The substantial reduction in compensation eased market concerns over the company's litigation risk exposure, providing positive short-term support for the stock price.Within the Pharmacy sector where Johnson & Johnson belongs, the overall sector displayed warm sentiment. Among individual stocks, Ligand Pharmaceuticals up 6.1%, Merck up 3.13%, Novo-Nordisk up 2.04%, Eli Lilly up 0.64%, Pfizer down 0.74%. The broader sector strength provided additional tailwinds for Johnson & Johnson's gains.Johnson & Johnson is a global leader in healthcare, operating through its Innovative Medicine and MedTech segments, covering therapeutic areas including immunology, oncology, neuroscience, cardiovascular, and surgical technologies.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1114805143","isCrawlerRequest":true}